Our services
We tailor our services to the client’s needs. Typical services before market access include charting of unmet needs, characterizations of target population and competition, projection of target population effects from randomised clinical trials, and design of structured follow-up programs. 

Services at the time of market access are centred around a novel pharmacoepidemiological model that we have developed and validated, the ”Sequentially Evaluated Nonrandomised Comparative Effectiveness (SENCE) model for structured continuous follow-up of new treatments.

The SENCE model can utilize data from electronic health records (EHR) and other complex data sources and is built to analyse data continuously, as soon as new information is generated in the clinical data sources, in order to provide timely evidence.

Typical services later in a product lifecycle include further comparative effectiveness studies and projections of target population effects.

Our principles
Our mission is to provide transparent and timely observational evidence for accelerated advancement of healthcare. We pre-register study protocols, fully disclose all methods used and publish all results specified in the protocols. We are ISO27001(Information Security Management) certified and subscribe to the ENCePP Code of Conduct and the ISPE Guidelines for Good Pharmacoepidemiology Practices. We take a lead in the development of methods and models for comparative effectiveness research.